M&A Deal Summary

Entelos Acquires Iconix Biosciences

On August 30, 2007, Entelos acquired life science company Iconix Biosciences for 14M USD

Acquisition Highlights
  • This is Entelos’ 2nd transaction in the Life Science sector.
  • This is Entelos’ largest (disclosed) transaction.
  • This is Entelos’ 2nd transaction in the United States.
  • This is Entelos’ 1st transaction in California.

M&A Deal Summary
Date 2007-08-30
Target Iconix Biosciences
Sector Life Science
Buyer(s) Entelos
Deal Type Add-on Acquisition
Deal Value 14M USD

Target

Iconix Biosciences

Mountain View, California, United States
Iconix Biosciences, Inc. is a provider of toxicogenomics products and services, has pioneered the integration of chemistry and genomics to enable the pharmaceutical and other industries to develop safer drug candidates and compounds.

Search 201,839 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Entelos

San Mateo, California, United States
Category Company
Founded 1996
Sector Life Science
DESCRIPTION

Entelos, Inc. is a US-based life sciences company applying next-generation predictive technologies to revolutionize the way medicines are discovered, developed, and utilized.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 2 of 2
State (California) 1 of 1
Country (United States) 2 of 2
Year (2007) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-05-26 Discovery Innovations

United States

Discovery Innovations is a specialized provider of data integration products and services to the life sciences.

Buy -
Mergr

Product

Company

Legal